First Edition: August 31, 2016
Today's early morning highlights from the major news organizations.
The independent source for health policy research, polling, and news.
36,441 - 36,460 of 112,633 Results
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
Outlets report on health news from Wisconsin, Georgia, California, Maryland, Tennessee, Arizona, Ohio, Washington, Michigan, Kansas, Missouri, Texas and Florida.
The state's Health Department is issuing several new policies following criticism that the process was too cumbersome.
The battle in California could influence bills pending in states across the country, including Pennsylvania, New Jersey, Georgia, Hawaii and Missouri.
As hardware prices drop, some doctors are trying out the new technology as a treatment option for a variety of conditions. In other health IT news, IBM bets big on health care. And more seniors are using mobile devices for virtual visits with their doctor.
Critics say the clinics -- which offer treatments costing thousands of dollars that have often not been tested for their efficacy -- are peddling snake oil to desperate Americans. In other public health news, scientists have found another superbug in the U.S., viruses in the gut are proven to be beneficial, a caregiver's story of her husband's final months and more.
“There appears to be a pervasive disregard for patient safety and public health by some within the pharmaceutical industry," Rep. Mark DeSaulnier and Rep. Ted Lieu said in calling for the House Oversight and Government Reform Committee to take action against the drugmaker.
The fight between key scientists and the prominent Michael J. Fox Foundation highlights the tension erupting as major medical research philanthropies increasingly seek to coordinate or manage studies, or control details of how they are done.
The project is an effort to give young doctors a taste of what a real-life courtroom will be like if they're called to the stand for a malpractice case. In other news, medical schools are starting to place more emphasis on adjusting nutrition rather than prescribing drugs.
The Atlantic Journal-Constitution looks at the disparity between how doctors and others are punished following reports of sexual abuse.
A partnership with the pharmacy benefits manager will gain the drugstore chain a greater share of the prescription drug market and position Walgreens to better compete with CVS.
Presidential candidate Hillary Clinton's proposal focuses on the integration of mental and physical health care systems, training police officers and suicide prevention. But some worry that, the funding necessary to make them successful is unrealistic.
The Republican governor, who bucked many in his party to support the health law's Medicaid expansion, says more than half a million state residents have gained coverage under the plan. In other news, Kentucky's only Democratic member of Congress criticizes the governor's plan to change the Medicaid expansion there, Idaho officials remain divided over efforts to expand the program, Oklahoma's Medicaid director resigns after some turbulent years and Tennessee enrolls more children in its Medicaid dental coverage.
The draft regulation would revamp the risk adjustment program for insurance companies and comes as several high-profile insurers have opted to cut back on participation in the exchanges. Meanwhile, Senate Majority Leader Mitch McConnell tells a business group that the law likely will be revamped next year, and some other Republican lawmakers are concerned that the administration tried to pressure Aetna.
Rather than starting from scratch, researchers test already-developed drugs -- and initial results are described as dramatic. Meanwhile, a new study finds that a female mosquito can transmit the virus to her eggs.
The generic version will cost $300, about half the price of the EpiPen-branded medication. But the company could actually end up making more in the end.
Today's early morning highlights from the major news organizations.
In its continuing response to the furor over its pricing for the lifesaving allergy drug, Mylan NV says it will offer an "identical" generic version of the medication for half the price of the branded version.
A selection of opinions on health care from around the country.
© 2026 KFF